Title : Fact File: Post Acute Respiratory and Cardiovascular Outcomes in Recovered COVID-19 Patients
Abstract:
Post COVID-19 pulmonary assessment revealed a persistent decrease in maximal oxygen consumption (VO? max) among previously symptomatic individuals. A proportion of patients particularly those with severe disease or ARDS exhibited reduced diffusion capacity for carbon monoxide (DLCO), fibrotic lung changes, and chronic dyspnea. Cardiovascular complications elevated D-dimer levels, fibrinogen, and delayed thrombin time were identified in severe cases, correlating with endothelial dysfunction and ongoing micro thrombotic events even after clinical recovery. Myocardial inflammation and pericardial involvement were also documented in post recovery imaging, indicating lingering vascular stress. Comorbid relationships adverse outcomes were significantly associated with underlying hypertension, cardiovascular disease, diabetes mellitus, and chronic pulmonary disorders. Multi organ implications persistent endothelial inflammation, microvascular injury, and dysautonomia (“post-COVID”) reflect systemic pathogenic footprints of SARS-CoV-2. COVID-19 recovery does not equate to full cardiopulmonary restoration for a notable subset of patients. Long-term monitoring indicates that recovered individuals remain susceptible to late-onset cardiac events (e.g., arrhythmias, myocarditis) and progressive pulmonary fibrosis. Rehabilitation focusing on graded exercise, respiratory therapy, and cardiovascular screening is recommended. Future research should emphasize longitudinal cohort tracking, biomarker profiling for enduring inflammation, and evaluating the efficacy of post-COVID rehabilitation programs.
